Clinical Trial: Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953869) titled 'Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia' on April 01.

Brief Summary: This is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female pediatric participants with insomnia disorder.

Study Start Date: April 21

Study Type: INTERVENTIONAL

Condition: Insomnia Disorder

Intervention: DRUG: Tasimelteon Oral Suspension

Single daily dose, weight-based liquid suspension formulation.

DRUG: Placebo

Placebo comparator.

Recruitment Status: RECRUITING

Sponsor: Vanda Pharmaceuticals

Disclaimer...